Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.
Tabernero J, Bahleda R, Dienstmann R, Infante JR, Mita A, Italiano A, Calvo E, Moreno V, Adamo B, Gazzah A, Zhong B, Platero SJ, Smit JW, Stuyckens K, Chatterjee-Kishore M, Rodon J, Peddareddigari V, Luo FR, Soria JC. Tabernero J, et al. Among authors: dienstmann r. J Clin Oncol. 2015 Oct 20;33(30):3401-8. doi: 10.1200/JCO.2014.60.7341. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324363 Clinical Trial.
Reply to R. Freitas-Junior et al.
Resende CAA, Dienstmann R, Mano MS. Resende CAA, et al. Among authors: dienstmann r. JCO Glob Oncol. 2023 Jun;9:e2300147. doi: 10.1200/GO.23.00147. JCO Glob Oncol. 2023. PMID: 37428992 Free PMC article. No abstract available.
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.
Duarte FA, Ferreira CG, Dienstmann R, Ferrari BL, Costa E Silva M, Nazareth A Junior P, Guilherme de O Salles P, Henrique C Diniz P. Duarte FA, et al. Among authors: dienstmann r. J Mark Access Health Policy. 2022 May 24;10(1):2077905. doi: 10.1080/20016689.2022.2077905. eCollection 2022. J Mark Access Health Policy. 2022. PMID: 36353186 Free PMC article.
Targeting the PI3K/Akt/mTOR pathway--beyond rapalogs.
Markman B, Dienstmann R, Tabernero J. Markman B, et al. Among authors: dienstmann r. Oncotarget. 2010 Nov;1(7):530-43. doi: 10.18632/oncotarget.101012. Oncotarget. 2010. PMID: 21317449 Free PMC article. Review.
BRAF as a target for cancer therapy.
Dienstmann R, Tabernero J. Dienstmann R, et al. Anticancer Agents Med Chem. 2011 Mar;11(3):285-95. doi: 10.2174/187152011795347469. Anticancer Agents Med Chem. 2011. PMID: 21426297 Review.
164 results